ArticlePain2026
Manual and automated capture of analgesic-responsive facial pain behaviors of unrestrained mice in a trigeminal neuralgia model.
Article in Pain, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
abstractTrigeminal neuralgia (TN), a devastating neuropathic pain condition, profoundly affects human well-being. Despite an initial response to carbamazepine (CBZ), many patients become refractory to pharmacotherapy and subsequent invasive procedures. Although preclinical trigeminal neuropathic pain models following extracranial chronic constriction injury (CCI) of the trigeminal nerve have been developed, the injury-induced facial hypersensitivity is rarely CBZ-responsive, questioning the models' relevance to TN. In recent reports, CBZ-responsive facial pain can be induced by intracranial CCI that better mimics the compression observed in classical TN. Nevertheless, behavioral assessment of persistent pain in these models often requires a restrained setting that could trigger unpredictable behaviors that are not necessarily pain associated. Here, we focused on spontaneous and evoked measures of pain in unrestrained mice after a CBZ-sensitive intracranial CCI, namely the FRICT-ION model. To measure these behaviors long-term, we developed a high-frame rate videography analysis that reliably captures increased chronic spontaneous asymmetric grooming and mechanically evoked facial rubbing, ipsilateral to the injury. Notably, this altered behavioral phenotype was significantly reversed by a nonsedating dose of CBZ. Using DeepLabCut tracking, we also found that the speed of head movement after facial mechanical stimulation is a significant CBZ-sensitive behavioral correlate of TN allodynia. Importantly, these behavioral measures accurately recapitulated the clinical outcomes-both success and failure-of a cohort of specific nonopioid analgesics that have previously been tested in the clinical management of TN. Together, these measures should greatly facilitate the research development of innovative TN therapies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.